Although, mentioned earlier, adiponectin has been reported to be increased in RA patients, an increase in adiponectin levels after treatment with antirheumatic drugs in patients with RA (41, 42, 43, 44) or after anti-TNF therapy in psoriatic arthritis patients (45) has also been described. This evidence concerns the gene ADIPOQ and rheumatoid arthritis.